6 results in Exploration of Drug Science
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Original Article
Subacute toxicity of isoliquiritigenin-zein phosphatidylcholine nanoparticles on biochemical, hematological, and histopathological parameters in Sprague-Dawley rats
Ke Yang ... Jianping Chen
Published: April 29, 2024 Explor Drug Sci. 2024;2:234–253
Open Access
Review
Lipopeptide adjuvants for antibiotics and vaccines: the future step in the fight against multidrug-resistant and extensively drug-resistant pathogens
Chloé O. Sebilleau, Steven J. Sucheck
Published: April 29, 2024 Explor Drug Sci. 2024;2:203–233
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Perspective
Daropeptide natural products
Suze Ma ... Qi Zhang
Published: April 19, 2024 Explor Drug Sci. 2024;2:190–202
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Review
Stapled peptides: targeting protein-protein interactions in drug development
Qian Zhang ... Chunqiu Zhang
Published: April 18, 2024 Explor Drug Sci. 2024;2:154–189
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Perspective
Clinical studies with drugs and biologics aimed at slowing or reversing normal aging processes—emerging results and future perspectives
Ricardo P. Garay
Published: April 10, 2024 Explor Drug Sci. 2024;2:144–153
This article belongs to the special issue Recent Advances with Investigational Compounds and Strategies to Delay or Reverse Normal Aging Processes
Open Access
Review
Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus
Alexander C. Martins ... Fernando Albericio
Published: April 03, 2024 Explor Drug Sci. 2024;2:126–143
Journal Information